Getting it right first time: national survey of surgical site infection 2019.


Journal

Annals of the Royal College of Surgeons of England
ISSN: 1478-7083
Titre abrégé: Ann R Coll Surg Engl
Pays: England
ID NLM: 7506860

Informations de publication

Date de publication:
Jul 2023
Historique:
pmc-release: 01 07 2024
medline: 3 7 2023
pubmed: 21 10 2022
entrez: 20 10 2022
Statut: ppublish

Résumé

Surgical site infections (SSIs) are associated with increased morbidity and mortality. Deep SSI, or prosthetic joint infection (PJI), is associated with revision surgery involving longer operative times with higher infection rates, longer length of stay (LoS) and high costs in addition to the catastrophic effect on the patient. The surveillance of SSI is important for patient decision making, identification of outliers for support and maximising focussed improvement. This paper reports the findings of the second Getting it Right First Time (GIRFT) national SSI survey for orthopaedic and spinal surgery. Data were submitted prospectively by 67 orthopaedic units and 22 spinal units between 1 May 2019 and 31 October 2019. For a patient to be included, they had to present with SSI within the study period and within 1 year of the index procedure. A total of 309 SSIs were reported from primary and revision, total hip, knee, shoulder, elbow and ankle replacements, and 58 SSIs were reported from lumbar spine single level discectomy or decompression, lumbar spine single-level instrumented posterior fusion, posterior cervical spine decompression and instrumented fusion and posterior correction of adolescent idiopathic scoliosis. SSIs rates have remained low compared with the 2017 survey. There were variations in SSI rates by procedure, with primary shoulder replacement reporting the lowest (0.4%) and revision shoulder replacement the highest (2.5%) rates. The authors recommend that the elective surgical restart following the COVID-19 pandemic provides a unique opportunity for all units to implement a full SSI prevention bundle to minimise the risk of infection and improve patient outcomes.

Identifiants

pubmed: 36263893
doi: 10.1308/rcsann.2022.0083
pmc: PMC10313457
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

513-522

Références

J Bone Joint Surg Am. 1972 Mar;54(2):207-36
pubmed: 4651258
Bone Joint J. 2017 Feb;99-B(2):171-174
pubmed: 28148657
Bone Joint J. 2017 Apr;99-B(4 Supple B):3-10
pubmed: 28363888
BMJ Open. 2017 Jul 10;7(7):e014056
pubmed: 28698316
J Bone Joint Surg Br. 2005 Jun;87(6):844-50
pubmed: 15911671
Bone Joint J. 2015 Sep;97-B(9):1170-4
pubmed: 26330581
BMC Med. 2020 Nov 18;18(1):335
pubmed: 33203455
Cleve Clin Q. 1973 Fall;40(3):99-114
pubmed: 4584720
Bone Joint J. 2019 Jan;101-B(1_Supple_A):3-9
pubmed: 30648488
J Bone Joint Surg Am. 2005 Aug;87(8):1746-51
pubmed: 16085614
Acta Orthop. 2015 Jun;86(3):277-8
pubmed: 25909277
Ann R Coll Surg Engl. 2019 Sep;101(7):463-471
pubmed: 31155919
Bone Joint J. 2016 Mar;98-B(3):334-40
pubmed: 26920958
Lancet Infect Dis. 2016 Dec;16(12):e288-e303
pubmed: 27816414
Acta Orthop Scand. 1987 Feb;58(1):4-13
pubmed: 3107337
PLoS One. 2016 Mar 03;11(3):e0150866
pubmed: 26938768
Am J Infect Control. 2008 Jun;36(5):309-32
pubmed: 18538699
J Bone Joint Surg Br. 2011 Jan;93(1):85-90
pubmed: 21196549
Acta Orthop. 2010 Oct;81(5):542-7
pubmed: 20860453
J Arthroplasty. 2017 Apr;32(4):1067-1073
pubmed: 27956126
Bone Joint J. 2018 Nov;100-B(11):1506-1510
pubmed: 30418053

Auteurs

S A Gatfield (SA)

Musgrove Park Hospital, UK.

K V Atkinson (KV)

The Royal London Hospital, UK.

D Fountain (D)

Salford Royal NHS Foundation Trust and University of Manchester, UK.

J T Machin (JT)

The Royal National Orthopaedic Hospital NHS Trust, UK.

A V Navaratnam (AV)

University London Hospitals NHS Foundation Trust, UK.

M Hutton (M)

Royal Devon and Exeter NHS Foundation Trust, UK.

Twr Briggs (T)

The Royal National Orthopaedic Hospital NHS Trust, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH